Phase 3 Study to Treat Patients With Soft Tissue Sarcomas

PHASE3CompletedINTERVENTIONAL
Enrollment

433

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

May 31, 2017

Study Completion Date

May 31, 2017

Conditions
Metastatic, Locally Advanced or Unresectable Soft Tissue Sarcoma
Interventions
DRUG

Aldoxorubicin

DRUG

Investigator's Choice Treatment (Darcabazine, Pazopanib, Gemcitabine + Docetaxel, Doxorubicin, Ifosfamide)

Trial Locations (74)

2730

Herlev Hospital, Herlev

14263

Roswell Park Cancer Institute, Buffalo

15232

U of Pittsburgh Cancer Institute, Pittsburgh

19107

Jefferson Medical College, Philadelphia

20141

Istituto Europeo di Oncologia Milano, Milan

27157

Wake Forest University Baptist Medical Center, Winston-Salem

28046

Hospital Universitario La Paz, Madrid

28204

Levine Cancer Institute, Charlotte

28220

Hospital Puerta de Hierro Majadahonda, Majadahonda

30341

Georgia Cancer Specialists, Atlanta

31008

Complejo Hospitalario de Navarra, Pamplona

32224

Mayo Clinic, Jacksonville

33612

Moffitt Cancer Center, Tampa

35128

Istituto Oncologico Veneto, Padua

35243

University of Alabama at Birmingham, Birmingham

37212

Vanderbilt University, Nashville

43202

The James Cancer Hospital and Solove Research Institute, Columbus

44106

University Hospitals Case Medical Center, Cleveland

44195

Cleveland Clinic, Cleveland

48109

University of Michigan, Ann Arbor

53226

Medical College of Wisconsin, Milwaukee

55455

University of Minnesota, Minneapolis

55905

Mayo Clinic, Rochester

60540

Edward Cancer Center, Naperville

60611

Northwestern Medical Faculty Foundation, Chicago

60714

Oncology Specialists, SC, Niles

63110

Washington University, St Louis

66210

Kansas City Cancer Center, Overland Park

68114

Nebraska Methodist Hospital, Omaha

80045

U of CO Health Sciences Center, Aurora

80218

Rocky Mountain Cancer Centers, Denver

85016

Arizona Oncology Associates, PC, Phoenix

85719

The University of Arizona, Tucson

90048

Samuel Oschin Cancer Center, Los Angeles

90095

UCLA Medical Center, Los Angeles

91010

City of Hope Medical Group, Duarte

94305

Stanford University Medical Center, Stanford

94800

Institut Gustave Roussy, Villejuif

97239

Center for Health and Healing, Portland

115478

"State Institution Blokhin Cancer Research Centre RAMS", Moscow

143423

City Oncology Hospital #2, Moscow

420029

Republican Clinical Oncologic Dispensary of Ministry of Health Republic Tatarstan, Tatarstan

940403

Sarcoma Oncology Center, Santa Monica

02114

Massachusetts General Hospital, Boston

02115

Dana Farber Cancer Institute, Boston

05405

Fletcher Allen Health Care, Burlington

Unknown

Royal North Shore Hospital, Saint Leonards

Westmead Hospital, Westmead

Cross Cancer Institute, Edmonton

Instituto Clinico Oncologica del Sur (ICOS), Temuco

Institut Bergonie, Bordeaux

Centre Leon Berard, Lyon

Centre Georges Francois Leclerc, Dijon

Centre Hospitalier Regional et Universitaire - Hospital Bretonneau, Tours

Hopital Rene Huguenin - Institut Curie, Saint-Cloud

Magyar Honvedseg Egeszsegugyi Kozpont, Budapest

Rambam Medical Center, Haifa

Sharet Institute of Oncology Hadassah Ein Karem Medical Center, Jerusalem

Chaim Sheba Medical Center, Ramat Gan

Tel Aviv Sourasky Medical Center, Tel Aviv

Fondazione del Piemonte per l'Oncologia, Candiolo

Azienda Ospedaliero-Universitaria di Bologna-Policlinico S Orsola-Malpighi, Bologna

IRCCS Instituto Ortopedico Rizzoli, Bologna

Instytut im.Marii Sklodowskiej-Curie, Warsaw

Consorcio Hospitalario Provincial de Castellon, Castellon

Inst Catala D'Oncologia, Barcelona

Centro Integral Oncologico Clara Campal, Hospital de Madrid Norte-San Chinarro, Madrid

Hospital San Carlos Madrid, Madrid

Hospital Universitario Miguel Servet, Zaragoza

LBV5C2

Juravinski Cancer Center, Hamilton

H2W156

McGill University, Montreal

2333ZA

Leiden Universitair Medisch Centrum, Leiden

08025

Hospital Universitario Son Espases, Palma de Mallorca

Hospital Santa Creu i Sant Pau, Barcelona

Sponsors

Lead Sponsor

All Listed Sponsors
lead

ImmunityBio, Inc.

INDUSTRY